Medicine

Dr. Yasser, Professor in Biochemistry, Dean of the Center for Research and Strategic Studies at Hajjah University, Yemen. HOD of Pharmacy Department. College of Medicine and Health Science, Hajjah University, Yemen. [email protected]. focuses on drug development, biochemical mechanisms of disease, and drug interactions, with a specific interest in the biological activity of compounds exhibiting anti-inflammatory, anticancer, antimicrobial, and anti-angiogenic properties. I utilize laboratory techniques, data analysis, and potentially clinical studies to advance understanding and improve drug efficacy and safety. My work involves student mentorship and collaboration

Dr Chia is a longevity scientist engaged in disease-free longevity, and preventing and reversing diabetes, hypertension, dementia, heart disease and cancer remission. Through breakthrough discoveries, it’s not science fiction anymore!

Sadia Salim is an environmental and public health researcher working on climate change, planetary and environmental health, WASH, sustainability, education and empowerment, and grassroots community development and resilience in vulnerable regions.

A public health researcher and educator specializing in epidemiology, biostatistics, and molecular biology, with a passion for advancing global health, infectious disease control, and data-driven public health solutions.

Professor Ru-Shi Liu, based at the Department of Chemistry, National Taiwan University (NTU) research interests span several areas, including investigating phosphor materials for light-emitting diodes (LEDs), exploring materials for energy conversion (such as water splitting, fuel cells, and batteries), and delving into the application of nanomaterials in medicine, particularly for photodynamic therapy.

Prof Jun Suzuki is a biochemist and the deputy director at the Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, Japan.

Chief Physician at Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, China.

Dr Yap is currently a Senior Lecturer and Program Director of Medical Bioscience at Monash University Malaysia. She is dedicated to toxin pharmacology and toxicology research. She has strong background in biomolecular modelling, proteomics, immunological and molecular pharmacology of bioactive toxins. She leads the Toxin Pharmacology Research Group. Her research group now focuses on molecular mechanisms of cytotoxin with the ultimate goal of developing next-generation biotherapeutics. Her research works have been featured in prominent media outlets, including the International Snakebite Awareness Day campaign. Besides active in research, she is also an education innovator who adopts various active learning strategies with technology. She teaches undergraduate units with an emphasis on student-cantered learning using the andragogy approach. Dr Michelle enjoys promoting STEM education to the public. She has organized and hosted several workshops and forums to advance the disciplines in medical sciences through research and education.

Dr Sarkar is a senior research fellow at the Murdoch Children's Research Institute in Melbourne, Australia. She is actively engaged in collaborating with academic and industry stakeholders and leads multiple projects for the development of novel therapeutics/vaccines to tackle antimicrobial resistance.

Ts. Uganeeswary Suparmaniam, AMIChemE (UK) is a multiple award-winning young scientist, sustainability advocate, and climate activist attached to the HICoE-Centre for Biofuel and Biochemical Research, Institute of Self-Sustainable Building, PETRONAS University of Technology, Malaysia.

Dr Linny Kimly Phuong is a paediatric infectious diseases physician and researcher. She holds appointments at the Royal Children’s Hospital, Cabrini Health and the Murdoch Children’s Research Institute. Linny’s areas of research include paediatric infections, Kawasaki disease and vaccine safety.

Sarfraz Ahmed is working as a Scientist at Harvard Medical School's Mass General Hospital. His research interests include Diseases and Therapeutics especially focus on Cancer and Therapeutics, Cancer Immunology, Photomedicine, Photo compounds and Photodevices for Cancer, Cancer and Natural agents, Nanomedicine and Nanotechnology for Cancer, Drugs resistance, Microbiology (Bacteriology & Virology) and Drugs resistance

I am a microbiologist currently working as a lecturer in the Medical Microbiology Department, Faculty of Applied Science, Hajjah University, Yemen. I am interested in research areas related to the prevalence of infectious diseases caused by bacteria, viruses, fungi, and parasites in different areas in Yemen.

I am a japanese physician-scientist in gastroenterology, especially in neurogastroenterology.

Epidemiologist working with health of marginalized groups, including migrants, informal houses residents, homeless and women caregivers.

Physician-researcher; Primary area of research: Ageing, at the individual and the population level; Geographical focus: Singapore, with some work in other Asian countries.

Taishi Yokoi is an Associate Professor of the Institute of Biomaterials and Bioengineering at Tokyo Medical and Dental University. His research areas include biomedical engineering, inorganic compounds and inorganic materials chemistry.

Dr. Zong-Hong Lin is a Professor at the Institute of Biomedical Engineering, National Tsing Hua University and at the Department of Biomedical Engineering, National Taiwan University.

Dr. Cheng-Siang Tan is an Associate Professor at the Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak (UNIMAS). He is an expert in infectious and emerging diseases and biosafety and biorisk management.

Miho Katsuragawa is a specially appointed project researcher at Kavli IPMU. Her areas of expertise include experimental physics, detector/instrument development, medical application of gamma-ray imaging, and high energy astrophysics.

Dr. Akira Kakugo is an Associate Professor at Hokkaido University. He has researched biomolecular motors and swarming of active matters.

Dr. Ashfaq Ahmad Shah 'اشفاک,' born on 6 June 1992, from south Kashmir, Dodarkoot ددیرکوٹ Kulgam, Jammu and Kashmir, India, is the microbiologist whose broad area of specialization incorporates infection immunity. He served as a researcher at the Graphic Era (Deemed to be University), Dehradun, UK, India, from 2020 to 2025. Currently he is working as Postdoctoral researcher and Junior Scientist in the KIET School of Pharmacy at KIET University. As a microbiology scientist, Dr. Shah has pursued novel dimensions of infection immunity pertaining to the correlation and impact of elicitation-triggered phytoalexins and phytoanticipins on the benign immune system of human beings. This parameter of immunology is termed phytoalexin-immunomodulation scrutiny in the contemporary era. Dr. Shah's research encompasses a range of areas, including the indagation on anti-inflammatory and antimicrobial compounds, evaluation of antibiotic resistance, study of immunomodulatory activities, disease model studies, protease isolation against specific protein antigens, study of novel compounds via the hyphenated techniques of GCMS, HPLC, FTIR-MS, etc., and the discipline of kalology, including tyrosinase inhibition, PPO inhibition, skin whitening agents, kerato-peeling, etc. Dr. Ashfaq is a scientist, doctoral researcher, reviewer, and editorial member of several journals and books of national and international repute. He has contributed extensively to scientific literature by publishing his research in journals of national and international repute. So far he has published more than forty infection/immunology/pharmacology scientific papers in Scopus and SCI-indexed journals, including two international books. In recognition of his contributions, Dr. Shah received the Young Scientist Award in August 2023 for his groundbreaking academic performance in the field of infection immunity. Dr. Shah has also been an active editor of Wikipedia pages in the field of medical science since 2015, with more than 1000 edits in medical topics available to medical literature worldwide.

Dr. Hira Khalid is serving as Associate Professor at Forman Christian College University, Lahore, Pakistan. She is also a US Fulbright Fellow and a member of several prestigious scientific organizations, including the American Chemical Society (ACS), the Royal Society of Chemistry (RSC), the International Union of Pure and Applied Chemistry (IUPAC), the Organization for Women in Science for the Developing World (OWSD), and the Chemical Society of Pakistan (CSP).

Dr. Tay has researched antibodies and diseases like malaria and SARS-CoV-2 at A*STAR. His focus is on discovering methods for developing antibodies that can be used in therapies against multidrug-resistant pathogens.

Professor Crumlish has researched aquatic microbial diseases, specifically ones that have economic impact in global aquaculture, and potential solutions to such infectious diseases. Her current project seeks to develop vaccines against antimicrobial resistance in aquaculture.

Dr. Singhal serves as senior principal investigator at the Bacterial Immunopathology Lab at A*STAR ID Labs in Singapore. His work at A*STAR ID Labs revolves around three main pathogens: Mycobacterium tuberculosis, Gram-negative bacteria and Dengue virus.

Professor St-Hilaire is a professor at the Department of Infectious Diseases and Public Health, City University of Hong Kong (CityU). She has extensively researched fish nutrition and diseases, including treatment efficacy, and has helped investigate fish disease outbreaks.

Dr. Oehlers leads the Bacterial Pathogenesis Laboratory at A*STAR ID Labs, where he and his colleagues focus on identifying molecular bases of mycobacterial disease and, thus, deploy therapies that address antibiotic resistance in mycobacterial infections.

Dr. Yue Wang is senior principal investigator at the Antifungal Resistance Laboratory of A*STAR ID Labs, where his body of work focuses on virulence mechanisms of the fungal human pathogen Candida albicans.